Potential Self-Peptide Inhibitors of the SARS-CoV-2 Main Protease.
Title | Potential Self-Peptide Inhibitors of the SARS-CoV-2 Main Protease. |
Publication Type | Journal Article |
Year of Publication | 2023 |
Authors | Banerjee A, Gosavi S |
Journal | J Phys Chem B |
Date Published | 2023 Jan 23 |
ISSN | 1520-5207 |
Abstract | The SARS-CoV-2 main protease (M) plays an essential role in viral replication, cleaving viral polyproteins into functional proteins. This makes M an important drug target. M consists of an N-terminal catalytic domain and a C-terminal α-helical domain (MC). Previous studies have shown that peptides derived from a given protein sequence (self-peptides) can affect the folding and, in turn, the function of that protein. Since the SARS-CoV-1 MC is known to stabilize its M and regulate its function, we hypothesized that SARS-CoV-2 MC-derived self-peptides may modulate the folding and the function of SARS-CoV-2 M. To test this, we studied the folding of MC in the presence of various self-peptides using coarse-grained structure-based models and molecular dynamics simulations. In these simulations of MC and one self-peptide, we found that two self-peptides, the α1-helix and the loop between α4 and α5 (loop4), could replace the equivalent native sequences in the MC structure. Replacement of either sequence in full-length M should, in principle, be able to perturb M function albeit through different mechanisms. Some general principles for the rational design of self-peptide inhibitors emerge: The simulations show that prefolded self-peptides are more likely to replace native sequences than those which do not possess structure. Additionally, the α1-helix self-peptide is kinetically stable and once inserted rarely exchanges with the native α1-helix, while the loop4 self-peptide is easily replaced by the native loop4, making it less useful for modulating function. In summary, a prefolded α1-derived peptide should be able to inhibit SARS-CoV-2 M function. |
DOI | 10.1021/acs.jpcb.2c05917 |
Alternate Journal | J Phys Chem B |
PubMed ID | 36689738 |